ENG
  • KOR
  • ENG

GC Cell’s cell research technology is not only domestic but also registered through various practical patent applications and registration.
It is also recognized overseas. Continuously publishing excellent research results in famous overseas journals, it is on par with scholars around the world.

  • Patent

  • Thesis

Total 22

ACTIVATED LYMPHOCYTE INCLUDING CYTOKINE INDUCED KILLER CELL AND PREPARING METHOD THEREOF

  • ·

    10-2019-0168127 | 10-2137954-0000
  • ·

    PCT/KR2020/005896

ACTIVATED LYMPHOCYTE AND PREPARING METHOD THEREOF

  • ·

    10-2019-0057532 | 10-2081585-0000

Mesothelin-specific chimeric antigen receptor and T lymphocyte expressing this chimeric antigen receptor

  • ·

    10-2019-0007422 / 10-2019-0077161 | 10-2216225-0000

PROCESS FOR ITS PREPERATION, THE LYMPOCYTE LONGTERMCRYOPRESERVATION FOR A CELLULAR IMMUNOTHERAPY

  • ·

    10-2004-0056280 | 10-0569609-0000

CHIMERIC ANTIGEN RECEPTOR AND NATURAL KILLER CELLS EXPRESSING SAME

  • ·

    10-2016-0181119
  • ·

    PCT/KR2017/015635 | WO 2018/124766

TRANSFORMED STEM CELL EXPRESSING GLB1 GENE AND PHARMACEUTICAL COMPOSITION FOR TREATING GM1 GANGLIOSIDOSIS COMPRISING SAME

  • ·

    10-2017-0079720 | 10-2065917-0000

METHOD FOR CULTURING NATURAL KILLER CELL, USING TRANSFORMED T CELL

  • ·

    10-2019-7030133 | 10-2020-0001595
  • ·

    PCT/KR2018/005983 | WO 2018/217064

ALLOGENEIC MESENCHYMAL STEM CELL AND USE THEREOF

  • ·

    10-2020-7003122 | 10-2269166-0000
  • ·

    PCT/KR2018/008651 | WO 2019/027214

NOVEL DRUG DELIVERY COMPOSITION AND PHARMACEUTICAL COMPOSITION FOR TREATING GM1 GANGLIOSIDOSIS COMPRISING THE SAME

  • ·

    10-2017-0177312 | 10-2137369-0000

Method for Preparing NK Cell

  • ·

    10-2019-0031875 | 10-2232321-0000